Health-related quality of life in patients with anaplastic astrocytoma during treatment with temozolomide
- 1 September 2000
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 36 (14) , 1788-1795
- https://doi.org/10.1016/s0959-8049(00)00165-9
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Multicenter Phase II Trial of Temozolomide in Patients With Anaplastic Astrocytoma or Anaplastic Oligoastrocytoma at First RelapseJournal of Clinical Oncology, 1999
- Interpreting the significance of changes in health-related quality-of-life scores.Journal of Clinical Oncology, 1998
- Effect of neurological dysfunction on health-related quality of life in patients with high-grade gliomaJournal of Neuro-Oncology, 1997
- Modification of the EORTC QLQ-C30 (version 2.0) based on content validity and reliability testing in large samples of patients with cancerQuality of Life Research, 1997
- The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30Quality of Life Research, 1996
- The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnairesQuality of Life Research, 1996
- Psychometric properties and responsiveness of the EORTC Quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancerQuality of Life Research, 1994
- A validation study of the domains of the core EORTC Quality of Life QuestionnaireQuality of Life Research, 1993
- Testing the EORTC Quality of Life Questionnaire on cancer patients with heterogeneous diagnosesQuality of Life Research, 1993
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993